<p>Characteristics of 108 bladder cancer patients treated with cisplatin-based adjuvant chemotherapy.</p
International audienceBackground: Cisplatin-based combination chemotherapy before surgery is the sta...
BackgroundCisplatin-based combination chemotherapy is the standard treatment for advanced urinary tr...
A trend towards greater benefit from adjuvant chemotherapy (ACT) in pN+ bladder cancer (BCa) has bee...
<p>Abbreviations: International Germ Cell Cancer Collaborative Group (IGCCCG); bleomycin etoposide c...
<p>Demographic and clinicopathological characteristics of bladder TCC patients.</p
Mt Sinai Hospital system and North Shore Long Island Jewish Health System, New York, New York. 2004–...
Between February 1988 and March 1993, 24 patients with locally advanced bladder cancer (stages T2-4N...
<p>Baseline characteristics of primary non-muscle invasive bladder cancer patients.</p
<p>Abbreviations: NMIBC, non-muscle invasive bladder cancer; MIBC, muscle invasive bladder cancer.</...
OBJECTIVE: To evaluate the comparative efficacy of adjuvant gemcitabine and cisplatin (GC) chemother...
<p>Abbreviations: PUC, pure urothelial carcinoma; VUC, variants of urothelial carcinoma; CCr, cleara...
<p>Univariate analysis of clinical characteristic influence on recurrence in 219 patients with bladd...
The aim of this study was to investigate the outcome of patients with muscle-invasive bladder cancer...
Bladder cancer is the 9th most common tumour worldwide with Urothelial Carcinoma (UC) being the most...
IF 11.855International audienceBackground:Cisplatin-based combination chemotherapy is the standard t...
International audienceBackground: Cisplatin-based combination chemotherapy before surgery is the sta...
BackgroundCisplatin-based combination chemotherapy is the standard treatment for advanced urinary tr...
A trend towards greater benefit from adjuvant chemotherapy (ACT) in pN+ bladder cancer (BCa) has bee...
<p>Abbreviations: International Germ Cell Cancer Collaborative Group (IGCCCG); bleomycin etoposide c...
<p>Demographic and clinicopathological characteristics of bladder TCC patients.</p
Mt Sinai Hospital system and North Shore Long Island Jewish Health System, New York, New York. 2004–...
Between February 1988 and March 1993, 24 patients with locally advanced bladder cancer (stages T2-4N...
<p>Baseline characteristics of primary non-muscle invasive bladder cancer patients.</p
<p>Abbreviations: NMIBC, non-muscle invasive bladder cancer; MIBC, muscle invasive bladder cancer.</...
OBJECTIVE: To evaluate the comparative efficacy of adjuvant gemcitabine and cisplatin (GC) chemother...
<p>Abbreviations: PUC, pure urothelial carcinoma; VUC, variants of urothelial carcinoma; CCr, cleara...
<p>Univariate analysis of clinical characteristic influence on recurrence in 219 patients with bladd...
The aim of this study was to investigate the outcome of patients with muscle-invasive bladder cancer...
Bladder cancer is the 9th most common tumour worldwide with Urothelial Carcinoma (UC) being the most...
IF 11.855International audienceBackground:Cisplatin-based combination chemotherapy is the standard t...
International audienceBackground: Cisplatin-based combination chemotherapy before surgery is the sta...
BackgroundCisplatin-based combination chemotherapy is the standard treatment for advanced urinary tr...
A trend towards greater benefit from adjuvant chemotherapy (ACT) in pN+ bladder cancer (BCa) has bee...
DOI
Add to ORKG